<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We used the polymerase chain reaction (PCR) to detect ALL1-AF4 rearrangements, the molecular hallmark of t(4;11) in a series of 46 pre-pre-B (CD19+, CD24+, CD10/CD20/cylgM/sIgM-) <z:hpo ids='HP_0006721'>acute lymphoblastic leukemias</z:hpo> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>Eighteen patients (39%) exhibited fusion transcripts including 4 of 12 children and 14 of 34 adults </plain></SENT>
<SENT sid="2" pm="."><plain>This genetic defect was associated with hyperleukocytosis (median leukocyte count 176 x 10(9)/L) and expression of myeloid-associated antigens (CDw65+) </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, only two patients from a group of 67 common (CD19/CD10+, cylgM/sIgM-) and <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALLs</z:e> (CD19/cylgM+, CD10 +/-, sIgM-) showed ALL1-AF4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> PCR-positive cases showed multiple amplification products representing alternative splicing events </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, reciprocal der (4)-derived AF4-ALL1 transcripts were observed in 65% of the cases analyzed </plain></SENT>
<SENT sid="6" pm="."><plain>Eight of the 18 pre-<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e> patients with an ALL1-AF4 recombination are currently in complete continuous remission for up to 54 months (median, 26 months) </plain></SENT>
<SENT sid="7" pm="."><plain>Twelve remission samples were available from seven cases, and <z:hpo ids='HP_0000001'>all</z:hpo> of them lacked evidence of <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Overall this study documents a similarly high incidence of ALL1-AF4 recombinations in children (infants excluded) and adults with <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-pre-B ALL</z:e> and demonstrates the decline of the leukemic cell clone below the detection level of PCR in a remarkable proportion of patients under intense treatment protocols </plain></SENT>
</text></document>